HomePharma & BiotechClinical Trial ManagementPreaching More Informed Clinical Trials to Access the Untapped Healthcare Precision

Preaching More Informed Clinical Trials to Access the Untapped Healthcare Precision

Research Solutions, a trusted provider of cloud-based workflow solutions to accelerate research for R&D-driven organizations, has officially announced the launch of a new Clinical Trial Landscape software solution, which is designed to make clinical trial information more accessible, insightful, and actionable. According to certain reports, the stated product leverages artificial intelligence to transform how medical science liaisons, medical affairs specialists, and clinical development teams explore, review, and synthesize multiple clinical trials and related data, thus helping them map the overall landscape quickly. By doing so, it basically addresses the critical need for comprehensive and bias-free access to global clinical trial information, as well as the need for a streamlined process in the context of identifying and summarizing available insights. This the solution, markedly enough, does using features, such as adverse event filtering, detailed analytics, and guided search and refinement. Talk about the whole value proposition on a slightly deeper level, though, we begin from the promise of enhanced PI discovery. Here, the core idea is rooted in using sophisticated analytics to help users generate heatmaps of the most frequent PIs in their disease space, and therefore, connect rather seamlessly with the top experts and their publications. Next up, we must get into how the software will bring to the fore a flexible research experience. You see, given the available assortment of field and filter options to tailor the search strategy (including, but not limited to, dates, sponsor type, and associated publications), researchers can configure their entire investigation process, and make it more focused upon the information that matters the most in their case.

“With our advanced AI and comprehensive data, we’re able to help teams and individuals navigate the vast landscape of clinical research, efficiently and effectively,” said Eléonore Dixon-Roche, Product Manager at Research Solutions.

Our final piece of highlight comes on the back of a streamlined access to global data sources. Such an access, like one might guess, goes a long distance to let researching teams aggregate data from trusted registries and databases like ClinicalTrials.gov, PubMed, and many others. This particular feature is there to conceive an end product which will deliver at your disposal the most relevant data, while simultaneously eliminating the risk of bias that has long remained associated with data curation.

The development in question delivers a rather intriguing follow-up to Research Solutions’ recent efforts towards becoming a leader in scientific data integration. For instance, not long ago, the company acquired ResoluteAI and scite to solidify its product ecosystem. Having referred to product, Research Solutions also, not long ago, launched a Technology Landscape solution. Designed specifically for the technology scouts, this one bears an ability to find, extract, and synthesize vital insights from many trusted sources, including patents, scientific journals, clinical trials, grants and the proprietary technology transfer opportunities database. Once in through the door, these insights then let the user generate comprehensive tech reports in a few minutes rather than several weeks.

Operating out of Henderson, Nevada, Research Solutions has risen up by providing cloud-based technologies that streamline the process of accessing, managing, and creating intellectual property. To be more specific, the company’s area of focus is, at the moment, concerned with Full-Text Literature Retrieval, Literature Tools: Monitoring, Management, Curation & Collaboration, Link Resolver Technology, Outsourced Publisher Services, and more. Research Solutions’ excellence in providing these solutions can also be understood once you consider that more than 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses rely on it to support their innovation process.

 

Must Read

Related News